En español
NIDA

NIDA Notes Articles: Addiction Science

NIDA Notes Category Graphic

EEG Indicates That Cocaine Relapse Vulnerability Peaks 1 to 6 Months Into Abstinence

September 2017
Electroencephalography (EEG) may provide an objective measure of cocaine-addicted participants’ vulnerability to cue-induced relapse. The assessment of cue-induced responsiveness may be useful in the clinical setting for assessing relapse risk and tailoring interventions to maintain abstinence among cocaine-addicted adults. 

NIDA Notes Category Graphic

Endocannabinoid Regulates Cocaine Reward

March 2017
Investigators have shown that 2-AG, an endocannabinoid (i.e., a cannabinoid manufactured within the body, as opposed to plant-derived), augments the cocaine-induced dopamine surge in the brain’s reward system. The discovery adds to evidence that inhibiting activity in the endocannabinoid system might reduce cocaine’s rewarding and addictive effects.  

NIDA Notes Category Graphic

Epigenetics: The Promise of a New Science

March 2008
Discusses the role of epigenetics, the study of cellular mechanisms that control gene expression and its impacts on health and behavior, in addiction research.

NIDA Notes Category Graphic

Extended Cocaine Exposure Impairs Cognitive Function in Rats

November 2009
Reports an animal study presenting evidence that cocaine causes cognitive deficits that can persist well into abstinence.

NIDA Notes Category Graphic

French Government Honors Dr. Volkow

October 2010
Announces the 2009 International Prize, awarded by the French Institute of Health and Medical Research, to NIDA Director Dr. Nora D. Volkow.

NIDA Notes Category Graphic

Gene Transfer Therapy for Cocaine Addiction Passes Tests in Animals

January 2016
Giving mice a modified version of a naturally occurring gene blocks cocaine’s stimulant effects without affecting the animals’ physiological or metabolic health. The new evidence advances the proposed therapy a step closer to readiness for testing in people.

NIDA Notes Category Graphic

Gene Variants Reduce Opioid Risks

June 2014
Two recent studies suggest that genotyping may enable clinicians to base therapies on individual patients’ potential responsiveness to opioid drugs’ therapeutic effects and vulnerability to their harmful effects.

NIDA Notes Category Graphic

Genetic Overlap Between Substance Abuse and Bipolar Disorder

April 2010
Describes a literature analysis reporting on the prevalence of people with bipolar disorder who also have a substance use disorder and discusses the genetic link that may contribute to this comorbidity.

NIDA Notes Category Graphic

Henry Yamamura Obituary

December 2008
Remembers Henry I. "Hank" Yamamura, an eminent neuropharmacologist who pioneered radioligand binding assays, contributing valuable knowledge about neurotransmitter transporters and receptors.

NIDA Notes Category Graphic

How-To Guides Provide Tips for Publishing Addiction-Related Articles

April 2010
Describes a book and online tutorial for young investigators of addiction science that provides tips for publishing their studies in scholarly journals.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics